PAMELA ANDERSON: Open Payments
NPI 1659693414 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,262 in 13 payments from 9 companies in 2025. Trend: 2023 $865 · 2024 $955 · 2025 $1,262
Food & beverage: $1,262
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 4 | $496 |
| Mallinckrodt Hospital Products Inc. | 2 | $267 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $124 |
| Amgen Inc. | 1 | $121 |
| Philips North America LLC | 1 | $71 |
| Terumo Medical Corporation | 1 | $22 |
| W. L. Gore & Associates, Inc. | 1 | $21 |
| MERZ NORTH AMERICA, INC. | 1 | $16 |
Products named: TERLIVAZ, Auvelity, Ozempic, UPLIZNA, IGT Devices Undivided, GLIDEWIRE, EXCLUDER Conformable AAA Endoprosthesis with Active Control, Xeomin.
Industry payments across IN — which companies pay providers there.
